W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.
Prof. Dittmar Böckler at the University of Heidelberg in Heidelberg, Germany, and Dr. Thomas Larzon at the Örebro University Hospital in Örebro, Sweden, were the first European physicians to implant the next generation Conformable GORE TAG Thoracic Endoprosthesis. Prof. Dittmar Böckler, vascular surgeon from the University of Heidelberg said, “The Conformable GORE TAG Device achieved excellent wall apposition and conformed to the thoracic aorta, thus allowing us to treat more patients with individual anatomies.”